Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma.
Tekin B, Cheville JC, Herrera Hernandez L, Negron V, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Cubilla AL, Whaley RD, Jimenez RE, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Tekin B, et al. Among authors: pagliaro lc. Hum Pathol. 2023 Dec;142:42-50. doi: 10.1016/j.humpath.2023.10.003. Epub 2023 Nov 15. Hum Pathol. 2023. PMID: 37977513
Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery.
Rodrigues Pessoa R, Zhang H, Zganjar A, Nabavizadeh R, Packiam VT, Lohse CM, Cheville JC, Pagliaro LC, Costello BA, Boorjian SA, Thompson RH, Lucien F, Dong H, Leibovich BC. Rodrigues Pessoa R, et al. Among authors: pagliaro lc. Urol Oncol. 2023 Sep;41(9):393.e1-393.e7. doi: 10.1016/j.urolonc.2023.05.009. Epub 2023 Jul 4. Urol Oncol. 2023. PMID: 37414595
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients.
Dasari S, McCarthy MR, Wojcik AA, Pitel BA, Samaddar A, Tekin B, Whaley RD, Raghunathan A, Hernandez LH, Jimenez RE, Stish BJ, Thompson RH, Leibovich BC, Boorjian SA, Jeffrey Karnes R, Childs DS, Quevedo JF, Kwon ED, Pagliaro LC, Costello BA, Halling KC, Cheville JC, Kipp BR, Gupta S. Dasari S, et al. Among authors: pagliaro lc. Prostate Cancer Prostatic Dis. 2024 Feb 27. doi: 10.1038/s41391-024-00814-2. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38413763
Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma.
Tekin B, Sali AP, Menon S, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Cubilla AL, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Tekin B, et al. Among authors: pagliaro lc. Hum Pathol. 2024 Jun;148:81-86. doi: 10.1016/j.humpath.2024.05.008. Epub 2024 May 22. Hum Pathol. 2024. PMID: 38782101
High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: A single institution experience.
Tekin B, Cubilla AL, Cheville JC, Smith CY, Jenkins SM, Dasari S, Enninga EAL, Norgan AP, Menon S, Whaley RD, Hernandez LH, Jimenez RE, Garcia JJ, Thompson RH, Leibovich BC, Karnes RJ, Boorjian SA, Pagliaro LC, Erickson LA, Guo R, Gupta S. Tekin B, et al. Among authors: pagliaro lc. Hum Pathol. 2024 Aug;150:9-19. doi: 10.1016/j.humpath.2024.06.013. Epub 2024 Jun 21. Hum Pathol. 2024. PMID: 38909709
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Mosalem O, Tan W, Bryce AH, Dronca RS, Childs DS, Pagliaro LC, Orme JJ, Kase AM. Mosalem O, et al. Among authors: pagliaro lc. Prostate Cancer Prostatic Dis. 2024 Feb 10. doi: 10.1038/s41391-024-00799-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38341460
Systematic Review and Meta-analysis of Minimally Invasive Procedures for Surgical Inguinal Nodal Staging in Penile Carcinoma.
Greco I, Fernandez-Pello S, Sakalis VI, Barreto L, Albersen M, Ayres B, Antunes Lopes T, Campi R, Crook J, García Perdomo HA, Johnstone PAS, Kailavasan M, Manzie K, Marcus JD, Necchi A, Oliveira P, Osborne J, Pagliaro LC, Parnham AS, Pettaway CA, Protzel C, Rumble RB, Sachdeva A, Sanchez Martinez DF, Zapala Ł, Tagawa ST, Spiess PE, Brouwer OR. Greco I, et al. Among authors: pagliaro lc. Eur Urol Focus. 2024 Jul;10(4):567-580. doi: 10.1016/j.euf.2023.11.010. Epub 2023 Dec 9. Eur Urol Focus. 2024. PMID: 38071107 Review.
[Initial presentation of the Pentafecta score as a quality instrument for outcome evaluation of primary surgical treatment in patients with penile cancer].
May M, Lebentrau S, Watkin N, Albersen M, Protzel C, Chahoud J, Brouwer OR, Pettaway CA, Pagliaro LC, Necchi A, Hakenberg OW, Ayres B, Spiess PE. May M, et al. Among authors: pagliaro lc. Aktuelle Urol. 2023 Aug;54(4):292-298. doi: 10.1055/a-2065-8256. Epub 2023 Jun 20. Aktuelle Urol. 2023. PMID: 37339668 German.
126 results